Extended matched intrauterine transfusions reduce maternal Duffy, Kidd, and S antibody formation

Transfusion

Volumn 55, Issue 12, 2015, Pages 2912-2919

  Schonewille, Henk ^a,b   Prinsen Zander, Karin J M ^b   Reijnart, Mila ^c   Van De Watering, Leo ^a,b   Zwaginga, Jaap Jan ^a,b   Meerman, Robertjan H ^b   Van Kamp, Inge L ^b   Brand, Anneke ^b  

^a SANQUIN RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; ERYTHROCYTE ANTIGEN; MATERNAL ANTIBODY; RHESUS ANTIGEN; VITRONECTIN; ALLOANTIBODY; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KIDD SYSTEM;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD SAMPLING; FEMALE; FETUS; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MAJOR CLINICAL STUDY; MATERNAL BLOOD; BLOOD; IMMUNOLOGY;

ANTIBODY FORMATION; BLOOD TRANSFUSION, INTRAUTERINE; DUFFY BLOOD-GROUP SYSTEM; FEMALE; HUMANS; ISOANTIBODIES; KIDD BLOOD-GROUP SYSTEM;

EID: 84959468333     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13231     Document Type: Article

References (15)

1. Koelewijn JM, Vrijkotte TG, de Haas M, et al., Risk factors for the presence of non-rhesus D red blood cell antibodies in pregnancy. BJOG 2009; 116: 655-64.
2. Lindenburg IT, van Kamp IL, Oepkes D., Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther 2014; 36: 263-71.
3. Viëtor HE, Kanhai HH, Brand A., Induction of additional red cell alloantibodies after intrauterine transfusions. Transfusion 1994; 34: 970-4.
4. Watson WJ, Wax JR, Miller RC, et al., Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease. Am J Perinatol 2006; 23: 189-92.
5. Schonewille H, Klumper FJ, van de Watering LM, et al., High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. Am J Obstet Gynecol 2007; 196: 143.e1-6.
6. Doyle B, Quigley J, Lambert M, et al., Red cell alloimmunisation following intrauterine transfusion and the feasibility of providing extended phenotype-matched red cell units. Transfus Med 2014; 24: 311-5.
7. Boujnan M, Sewsahai R, Jongerius JM., Extended red blood cell phenotyping in the Netherlands. Vox Sang 2013; 102 Suppl 1: 200.
8. Gordon MC, Kennedy MS, O'Shaughnessy RW, et al., Severe hemolytic disease of the newborn due to anti-Js(b). Vox Sang 1995; 69: 1411.
9. Denomme GA, Ryan G, Seaward PG, et al., Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17. Transfusion 2004; 44: 1357-60.
10. Lydaki E, Nikoloudi I, Kaminopetros P, et al., Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant women alloimmunized with anti-Ku. Transfusion 2005; 45: 1791-5.
11. Bleile MJ, Rijhsinghani A, Dwyre DM, et al., Successful use of maternal blood in the management of severe hemolytic disease of the fetus and newborn due to anti-Kp(b). Transfus Apher Sci 2010; 43: 281-3.
12. Al Riyami AZ, Al Salmani M, Al Hashami S, et al., Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature. Transfusion 2014; 54: 238-43.
13. Gonsoulin WJ, Moise KJ Jr, Milam JD, et al., Serial maternal blood donations for intrauterine transfusion. Obstet Gynecol 1990; 75: 158-62.
14. Qi X, Wagner A, Mnich T, et al., High incidence of formation of additional Rh antibodies in Rh(D)-sensitized patients after intrauterine transfusion [abstract]. Transfusion 2014; 54 Suppl S2: 18A.
15. Bontekoe IJ, Scharenberg J, Schonewille H, et al., A new preparation method for red blood cells for intrauterine transfusion enabling reduction of donor exposure. Transfusion 2015; 55: 1693-9.